Amantadine increases aromatic L-amino acid decarboxylase mRNA in PC12 cells

Journal of Neuroscience Research

Volumn 53, Issue 4, 1998, Pages 490-493

  Li, Xin Min ^a,b   Juorio, Augusto V ^a   Qi, Jin ^a   Boulton, Alan A ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Amantadine; Aromatic L amino acid decarboxylase; PC12 cells

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPA; DOPAMINE; LEVODOPA; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; DOPAMINE METABOLISM; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT;

AMANTADINE; ANIMALS; AROMATIC-L-AMINO-ACID DECARBOXYLASES; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; KINETICS; PC12 CELLS; RATS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0031928715     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980815)53:4<490::AID-JNR11>3.0.CO;2-6     Document Type: Article

References (33)

1. Barbeau A, Sourkes TL, Murphy GF (1962): Les catécholamines dans la maladie de Parkinson. In Ajuriaguerra J de (ed): "Monoamines et Système Nerveux Central." Paris: Masson, pp 247-262.
2. Birkmayer W, Hornykiewicz O (1961): Der L-3,4-dioxyphenylalanin (L-DOPA)-effekt bei der Parkinson-Akinese. Wien Klin Wochenschr 73:787-788.
3. Blaschko H (1945): The amino acid decarboxylases of mammalian tissues. Adv Enzyme Regul 5:67-85.
4. Boulton AA, Juorio AV (1982): Brain trace amines. In Lajtha A (ed): "Handbook of Neurochemistry." Vol. 1, 2nd ed. New York: Plenum Press, pp 189-222.
5. Brodie BB, Kuntzman R, Hirch CW, Costa E (1962): Effects of decarboxylase inhibition on the biosynthesis of brain monoamines. Life Sci 1:81-84.
6. Carlsson A (1995): Neurocircuitries and neurotransmitter interactions in schizophrenia, Int Clin Psychopharmacol (suppl) 10:21-28.
7. Cotzias GC, Van Woert MH, Schifter LM (1967): Aromatic amino acid and modification of parkinsonism. N Engl J Med 276:374-379.
8. Danysz W, Gossel M, Zajaczkowski W, Dill D, Quack G (1994): Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats? Case of amantadine and memantine. J Neural Transm Park Dis Dement Sect 7:155-166.
9. Danysz W, Parsons CG, Kornhuber J, Schmidt WJ, Quack G (1997): Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents-preclinical studies. Neurosci Behav Rev 21:455-468.
10. Ehringer H, Hornykiewicz O (1960): Verteilung von noradrenalin und dopamin (3-hydroxytyramin) im gehirn des menschen und ihr verhalten bei erkrankungen des extrapyramidalen systems. Klin Wochenschr 38:1236-1239.
11. Fainberg AP, Vogelstein B (1983): A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13.
12. Fisher A, Biggs CS, Starr MS (1998): Effects of glutamate antagonists on the activity of aromatic L-amino acid decarboxylase. Amino Acids 14:43-49.
13. Gjedde A, Léger GC, Cummings P, Yasuhara Y, Evans AC, Guttman M, Kuwabara H (1993): Striatal L-Dopa decarboxylase activity in Parkinson's disease in vivo: Implications for the regulation of dopamine synthesis. J Neurochem 61:1538-1541.
14. Greene LA (1982): PC12 pheochromocytoma cultures in neurobiological research. Adv Cell Neurobiol 3:373-414.
15. Hadjiconstantinou M, Rossetti ZL, Silvia C, Krajnc D, Neff NH (1988): Aromatic L-amino acid decarboxylase activity of the rat retina is modulated in vivo by environmental light. J Neurochem 51:1560-1564.
16. Hadjiconstantinou M, Wemlinger TA, Sylvia CP, Hubble JP, Neff NH (1993): Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors. J Neurochem 60:2175-2180.
17. Hadjiconstantinou M, Rossetti ZL, Wemlinger TA, Neff NH (1995): Dizocilpine enhances striatal tyrosine hydroxylase and aromatic L-amino acid decarboxylase activity. Eur J Pharmacol 289:97-101.
18. Juorio AV, Li XM, Walz W, Paterson IA (1993): Decarboxylation of L-Dopa by cultured mouse astrocytes. Brain Res 626:306-309.
19. Lange KW, Kornhuber J, Riederer P (1997): Dopamine/glutamate interactions in Parkinson's disease. Neurosci Behav Rev 21:393-400.
20. Li X-M, Juorio AV, Paterson IA, Zhu MY, Boulton AA (1992a): Specific irreversible MAO B inhibitors stimulate gene expression of aromatic L-amino acid decarboxylase in PC12 cells. J Neurochem 59:2324-2327.
21. Li X-M, Juorio AV, Paterson IA, Walz W, Zhu MY, Boulton AA (1992b): Gene expression of aromatic L-amino acid decarboxylase in rat cultured glial cells. J Neurochem 59:1172-1175.
22. Li X-M, Juorio AV, Boulton AA (1993): NSD-1015 alters gene expression of aromatic 1-amino acid decarboxylase (AADC) by in rat PC12 pheochromocytoma cells. Neurochem Res 18:915-919.
23. Li X-M, Qi J, Juorio AV, Boulton AA (1997): NGF regulate the gene expression of aromatic L-amino acid decarboxylase and tyrosine hydroxylase in PC12 cells. J Neurosci Res 47:449-454.
24. Maniatis T, Fritsch EF, Sambrook J (1982): "Molecular Cloning, A Laboratory Manual." New York: Cold Spring Harbor.
25. Melamed E, Hefti F, Pettibone DJ, Liebman J, Wurtman, RJ (1981): Aromatic L-amino acid decarboxylase in rat corpus striatum: Implications for action of L-Dopa in Parkinsonism. Neurology 31:651-655.
26. Rojas P, Altagracia M, Kravzov J, Rios C (1993): Amantadine increases striatal dopamine turnover in MPTP-treated mice. Drug Dev Res 29:222-226.
27. Scatton B, Cheramy A, Besson MJ, Glowinski J (1970): Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment. Eur J Pharmacol 13:131-133.
28. Schubert D, Kimura H, Maher P (1992): Growth factors and vitamin E modify neuronal glutamate toxicity. Proc Natl Acad Sci USA 89:8264-8267.
29. Schwab RS, England AC, Poskanzer DC, Young RR (1969): Amantadine in the treatment of Parkinson's disease. JAMA 208:1168-1170.
30. Stefanis L, Burke RE, Greene LA (1997): Apoptosis in neurodegenerative disorders. Curr Opin Neurol 19:299-305.
31. Tanaka T, Horio Y, Taketoshi M, Imamura I, Ando-Yamamoto M, Kangawa K, Matsuo H, Kuroda M, Waka H (1989): Molecular cloning and sequencing of a cDNA of rat dopa decarboxylase, partial amino acid homologies with other enzymes synthesizing catecholamines. Proc Natl Acad Sci USA 86:8142-8146.
32. von Voigtlander PF, Moore KE (1970): Dopamine: Release from the brain in vivo by amantadine. Science 174:408-410.
33. Zhu MY, Juorio AV, Paterson IA, Boulton AA (1992): Regulation of aromatic 1-amino acid decarboxylase by dopamine receptors in the rat brain. J Neurochem 58:636-641.